Gilead Sciences
GILD
#105
Rank
NZ$292.45 B
Marketcap
NZ$235.69
Share price
1.72%
Change (1 day)
36.97%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): NZ$11.23

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is NZ$10.83. In 2024 the company made an earnings per share (EPS) of NZ$0.63 a decrease over its 2023 EPS that were of NZ$7.55.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$11.231679.25%
2024NZ$0.63-91.65%
2023NZ$7.5523.98%
2022NZ$6.09-25.86%
2021NZ$8.224850%
2020NZ$0.17-97.64%
2019NZ$7.040.9%
2018NZ$6.9818.71%
2017NZ$5.88-64.88%
2016NZ$16.74-18.45%
2015NZ$20.5255.28%
2014NZ$13.22296.02%
2013NZ$3.3417.89%
2012NZ$2.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.86-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.24-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$34.07 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.64 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$18.25 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$7.42-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$23.79 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA